Phase II study of capecitabine plus trastuzumab in human epidermal growth factor receptor 2 overexpressing metastatic breast cancer pretreated with anthracyclines or taxanes. (Q52925550)
Jump to navigation
Jump to search
scientific article published on 18 June 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of capecitabine plus trastuzumab in human epidermal growth factor receptor 2 overexpressing metastatic breast cancer pretreated with anthracyclines or taxanes. |
scientific article published on 18 June 2007 |
Statements
Phase II study of capecitabine plus trastuzumab in human epidermal growth factor receptor 2 overexpressing metastatic breast cancer pretreated with anthracyclines or taxanes. (English)
Gerhard Schaller
Ilka Fuchs
Thomas Gonsch
Jan Weber
Anke Kleine-Tebbe
Peter Klare
Hans-Joachim Hindenburg
Volker Lakner
Axel Hinke
Nikola Bangemann
18 June 2007
25
22
3246-3250